What antibiotics are in the meropenem class (and what are they used for)?
Meropenem is a carbapenem antibiotic, part of the beta-lactam family. Carbapenems are typically used for serious bacterial infections, including infections caused by many gram-positive and gram-negative organisms, and they are often considered when other antibiotics may not be sufficient.
Because “the meropenem class” can be used loosely by patients to mean “other drugs like meropenem,” the main class members are other carbapenems (same general drug class, similar mechanism and spectrum).
Which other carbapenem antibiotics are similar to meropenem?
Common carbapenems include:
- Imipenem (often given with cilastatin to reduce breakdown in the body)
- Ertapenem
- Doripenem (in some markets/settings)
These are clinically related to meropenem in that they share the carbapenem beta-lactam structure and are used for serious infections.
How does meropenem work compared with other beta-lactams?
Meropenem works by inhibiting bacterial cell-wall synthesis. Like other beta-lactam antibiotics, it targets enzymes involved in building and maintaining the bacterial cell wall, leading to bacterial death.
Carbapenems are generally known for a broad spectrum of activity and stability against many beta-lactamases (enzymes that break down some antibiotics), which is a key reason they’re used for hard-to-treat infections.
Is “meropenem class” the same thing as “broad-spectrum antibiotic”?
Not exactly. “Meropenem class” is about drug family (carbapenem beta-lactams). “Broad-spectrum” is about how many types of bacteria an antibiotic can cover. Meropenem is broad-spectrum, but other broad-spectrum antibiotics (for example, some cephalosporins or fluoroquinolones) are not in the meropenem/carbanem class.
What side effects and risks are most associated with meropenem?
Common patient concerns with meropenem (similar to many beta-lactams) can include gastrointestinal effects, rash, and allergic reactions. Serious risks can include severe hypersensitivity reactions and seizures in susceptible patients (the seizure risk can be influenced by factors such as kidney function and overall clinical situation).
If you’re asking for this because of a specific medication order, it helps to know the dose and the patient’s kidney function.
Can meropenem be replaced with another “meropenem-class” drug?
Clinicians sometimes switch between carbapenems based on factors like infection type, local resistance patterns, dosing convenience, and patient-specific issues (especially kidney function and prior antibiotic exposure). For some infections, ertapenem may be considered because it’s carbapenem-class and often used for certain bacterial targets, but choice depends on the clinical scenario and expected bacteria.
If you tell me the infection being treated (or the reason meropenem was selected), I can help map which carbapenem is usually considered in that situation.